4.3 Article

Developing a clinical pathway to identify and manage cognitive problems in Multiple Sclerosis: Qualitative findings from patients, family members, charity volunteers, clinicians and healthcare commissioners

Journal

MULTIPLE SCLEROSIS AND RELATED DISORDERS
Volume 49, Issue -, Pages -

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.msard.2020.102563

Keywords

Multiple sclerosis; Stakeholder perspective; Cognitive screening; Cognitive management; Pathway; Qualitative

Funding

  1. National Institute for Health Research [RP-PG-0218-20002]
  2. National Institutes of Health Research (NIHR) [RP-PG-0218-20002] Funding Source: National Institutes of Health Research (NIHR)

Ask authors/readers for more resources

The study collected and synthesized stakeholder perspectives to develop a care pathway for cognitive problems in MS, producing a logic model. The proposed pathway was perceived as helpful in providing standardized support for a neglected MS symptom. Training packages, online cognitive screening, and triaging decisions were viewed as crucial activities.
Background: Cognitive problems are a common and debilitating symptom of multiple sclerosis (MS). Screening and treatment for cognitive problems are recommended, however these are not routinely delivered in UK clinics. We collected and synthesised stakeholder perspectives to develop a care pathway for cognitive problems in MS and produce a logic model, illustrating how this pathway might operate. Methods: Forty-nine stakeholders, including people with MS and care providers, participated in semi-structured interviews and focus groups. Participants viewed information that illustrated how the pathway might work and provided feedback. Data, transcribed verbatim and analysed using Framework Analysis, were mapped onto a preliminary logic model and accompanying thematic framework. Results: The proposed pathway was perceived as helpful in providing standardised support for a neglected MS symptom. Training packages, online cognitive screening, and triaging decisions were viewed as crucial activities. Shared responsibility, a person-centred approach, and addressing the complexity of cognitive problems were important engagement mechanisms. Allocating time during clinic appointments and within staff workloads were essential resources for implementation. Conclusion: Our co-constructed MS cognitive screening and management pathway will be evaluated for clinical and cost-effectiveness in a trial. However, in the interim, clinicians can adapt and implement this pathway in their own services and evaluate it locally.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available